`

ComboCap, Inc

Pharmaceutical Manufacturing

Specialities :
World's only patented dual-chamber
Wet/dry capsule
Manufacturing on patented specialty equipment
Formulation to fulfillment
Nutraceuticals

+3

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About ComboCap, Inc

What does Combocap, inc do?+

ComboCap, Inc. (formerly known as Binutra USA) is a technology company with global potential in the pharmaceutical & nutraceutical industries that has developed the worlds first dual-chamber oral capsule with a movable membrane. This patented technology targets the burgeoning global combination therapy products market where no universally attractive wet & dry, split-dose solution exists. ComboCap has developed specialized manufacturing equipment and services to offer customized products as well as turn-key customized finished product solutions to clients worldwide

What are Combocap, inc's specialties? +

World's only patented dual-chamber,wet/dry capsule,manufacturing on patented specialty equipment,formulation to fulfillment,nutraceuticals,dietary supplements,otc and rx pharmaceuticals,and combination therapies

What is Combocap, inc's industry? +

Combocap, inc operates in the Pharmaceutical manufacturing industry.

What is Combocap, inc's revenue? +

Combocap, inc's revenue is 11m - 100m

What is Combocap, inc's company size? +

Combocap, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.